The coronavirus vaccine being developed by AstraZeneca may be facing delays. The British health authority MHRA already gave permission for trials to restart, but the American FDA - where the majority of testing is done - is still dithering, AD reports. The American shutdown could have consequences for when European member states, including the Netherlands who already bought 300 million …
